Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scherer vitamin E, health & nutrition softgel sales show "strong gains" in first quarter.

This article was originally published in The Tan Sheet

Executive Summary

SCHERER VITAMIN E, HEALTH & NUTRITIONAL SOFTGEL "STRONG GAINS" helped boost overall sales for fiscal 1997 (ended March 31), the soft gelatin capsule manufacturer reported May 12. Consolidated sales for the fiscal year were $588.7 mil., up 2.9% from the $571.7 mil. reported in FY 1996. R.P. Scherer said the current year sales rise "resulted primarily from a 40% increase in Zydis revenues and strong gains in vitamin E and H&N softgel sales" in the U.S., U.K. and Australia. Vitamin E sales accounted for quite a bit of that gain, Scherer said. The gains were partially offset by several factors, including "weak demand for all types of softgel products in continental Europe," as well as lower Rx nifedipine and flat Sandimmune/Neoral sales, Scherer noted.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087075

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel